Purpose: The objective was to determine the optimal insemination technique in patients undergoing in vitro fertilization (IVF) after failed direct intraperitoneal insemination (DIPI) and the outcome of intracytoplasmic sperm injection (ICSI
INTRODUCTION
The prevalence of infertile couples without any identifiable cause (unexplained infertility) has been reported to vary between 1% and 37% (1) . Intrauterine insemination (IUI), especially direct intraperitoneal insemination (DIPI), with previously reported pregnancy rates of 22.7% (2) , 23.0% (3), or 35.6% (4), appears to offer the advantage of being a relatively noninvasive way of dealing with unexplained infertility and is well worth trying before moving on to more invasive and costly approaches such as gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF). Gurgan et al. (5) and Ruiz et al. (6) reported that there was a higher incidence of total fertilization failure events in couples with unexplained infertility. However, the prognosis of couples failing to conceive with superovulation and DIPI is unknown. Furthermore, it remains to be defined whether couples failing to conceive with superovulation and DIPI represent a less favorable subset of patients for subsequent treatment with more sophisticated means of assisted reproduction. The present study was designed to determine the prognosis after IVF and subsequent ICSI in couples with unexplained infertility failing to conceive with superovulation and DIPI.
MATERIALS AND METHODS

Patient Selection
The patients were divided into four groups according to the underlying indication for IVF or ICSI. The first IVF group consisted of 53 patients with unexplained infertility who had failed to conceive with four to six episodes of superovulation and DIPI. The second group consisted of 75 patients undergoing IVF because of endometriosis or a tubal factor. The third group consisted of 30 patients undergoing ICSI because of failed fertilization or a low fertilization rate in the first group. The fourth group consisted of 58 patients undergoing ICSI because of severe male factor problems according to the criteria of the World Health Organization (WHO) (7) . Unexplained infertility was defined as a normal semen analysis according to the criteria of the WHO, including the absence of antisperm antibodies, and postcoital test. Endometriosis was diagnosed by laparoscopy or laparotomy.
Ovarian Stimulation and Oocyte Collection
Ovarian stimulation was carried out by a desensitizing protocol using the gonadotropin-releasing hormone agonist (GnRHa) buserelin acetate (Supurecur; Hoechst Japan) in combination with human manopausal gonadotropin (hMG) (Humegon; Organon, Japan; or Pergogreen; Seronol Japan). The response to stimulation was determined by serial estradiol determination and ovarian ultrasonograms. When the leading follicle achieved a diameter of 18 mm, human chorionic gonadotropin (hCG) (10,000 IU) was administered and transvaginal ultrasoundguided oocyte retrieval was carried out 36 hr later. hCG injection (1500 IU) on days 2 and 4 and intravaginal micronized progesterone (400 mg/day) were given for luteal support.
Preparation of Sperm
Semen samples were allowed to liquefy for 20 min, prepared with the standard swim-up technique for IVF, and processed through discontinuous Percoll gradients (40% and 90%) for ICSI. Percolled sperm pellets were washed twice and resuspended in HEPES buffered human tubal fluid (modified-HTF, Irvine Scientific, CA) before use. 
Preparation of Oocytes
Oocytes were rinsed thoroughly and kept in HTF with 10% heat-inactivated maternal serum [insemination medium, (IM)] for up 5 hr at 37ЊC under 5% CO 2 in air. For IVF, fertilized oocytes were transferred to growth medium consisting of HTF with 15% heatinactivated maternal serum. For preparation of ICSI, the cumulus was removed by repeated aspiration into glass pipettes in modified-HTF with 0.025% hyaluronidase type VIII (Sigma Chemical Co.). Denuded oocytes were thoroughly rinsed and returned to the IM. Only metaphase II oocytes were used for ICSI.
Intracytoplasmic Sperm Injection
The ICSI procedure was performed according to the method described by Kimura and Yanagimachi (8) with minor modifications. Briefly, several piezopulses (intensity 2, speed 2) were administered to advance the pipette until its tip passed through the zona pellucida. The pipette then was advanced quickly and manually through the ooplasm until it reached one third of the distance to the opposite side of the cortex of the oocyte. The oolemma was broken (as confirmed by its relaxation) using a light negative pressure without piezo-pulses.
The cover (10 mm in depth) of a plastic dish (60 ϫ 15 mm) (Falcon Plastics, Oxford) was used as a microinjection chamber. A row consisting of two round droplets and three elongated drops was placed along the center line of the dish. The first droplet (3 Ȑl) was formed from 10% polyvinylpyrrolidone (PVP) (Sigma) dissolved in Dulbecco phosphate-buffered saline (GIBCO BRL) and was for washing the pipette. The second droplet (3 Ȑl) was a suspension of sperm in 10% PVP. The third elongated droplet (3 Ȑl) was modified-HTF containing prepared sperm. The fourth and fifth elongated droplets (3 Ȑl) were for the oocytes. These droplets were covered with mineral oil (Sigma). The dish was placed on the stage of an inverted microscope (Olympus, Tokyo, Japan) and its contents viewed with the aid of Nomarski differential interference optics. Motile sperm were aspirated from the suspension into the injection pipette, transferred to a drop containing an oocyte, and immobilized by crushing the tail between the injection pipette and the dish. Intracytoplasmic sperm injection was performed on the microscope. After injection, oocytes were transferred to growth medium consisting of HTF with 15% heat-inactivated maternal serum.
Survival, Fertilization, and Embryo Cleavage
The oocytes were deemed to have survived the ICSI procedure if they remained intact and failed to show any obvious signs of lysis or degeneration over the 2 days following injection. Oocytes were examined for fertilization approximately 16 to 18 hr after injection. Normal fertilization was considered to have occurred when two clearly distinct pronuclei (PN) were present. The number of abnormal fertilizations, such as oocytes with one PN or three PN, also was recorded. After another 24-hr in vitro culture, three or four embryos were transferred into the uterus. Embryos were classified following the Veeck classification. Clinical pregnancies were confirmed by the presence of a gestational sac on ultrasonography 4 to 6 weeks after embryo transfer.
Statistical Evaluation
Data were expressed as a mean Ϯ SEM values. For statistical comparisons, the 2 test was employed. A value of P Ͻ 0.05 was considered to be statistically significant.
RESULTS
IVF was performed for 53 patients (53 cycles) with unexplained infertility who had failed to conceive with four to six episodes of superovulation and DIPI and 75 patients (128 cycles) because of endometriosis or tubal factor problems (Table I) . Age, the dose of menotropin administration, estradiol level, progesterone level, endometrial thickness on hCG administration, the number of retrieved oocytes per patient, and surviving rate for insemination oocytes did not differ statistically significantly between the groups. The fertilization rate, when total fertilization failure was excluded from the analysis, was significantly lower for the group of patients with unexplained infertility who had failed to conceive with DIPI (52.0%, respectively) than for the endometriosis or tubal factor group (68.4%, respectively) (P Ͻ 0.01). The incidence of total fertilization failure was 30.2% and 3.9% in the group of patients with unexplained infertility who had failed to conceive with DIPI and the endometriosis or tubal factor group, respectively (P Ͻ 0.01). The cleavage rate was significantly higher in the group patients with unexplained infertility who had failed to conceive with DIPI (96.4%) than in the endometriosis or tubal factor group (89.9%) (P Ͻ 0.01). The morphological quality of the oocytes cleaved, mean number of embryos transferred, and embryo implantation rates were similar in both groups. The pregnancy rate per embryo transfer, when events of total fertilization failure or low fertilization rate were excluded from the analysis was similar in both groups (54.2% and 36.8%, respectively). The embryo transfer cycle cancellation rate was significantly higher in the group of patients with unexplained infertility who had failed to conceive with DIPI (57.4%) than in the endometriosis or tubal factor group (10.9%) (P Ͻ 0.01).
ICSI was performed for 30 patients (49 cycles) because of failed fertilization or a low fertilization rate in the first group and 58 patients (98 cycles) because of severe male factor (Table II) . Age, the dose of menotropin administration, estradiol level, progesterone level, endometrial thickness on hCG administration, the number of retrieved oocytes per patient, and survived rate for inseminated oocytes did not differ statistically significantly between the groups. The fertilization rate was slightly but significantly lower in the group patients with failed fertilization or a low fertilization rate (85.8%) than in severe male factor group (90.4%) (P Ͻ 0.05). Total fertilization failure was not observed in either group. The cleavage rate was significantly higher in the group of patients with failed fertilization or a low fertilization rate (93.9%) than in severe male factor group (83.9%) (P Ͻ 0.01). The morphological quality of the oocytes cleaved, mean number of embryos transferred, embryo implantation rate, pregnancy rate per embryo transfer, and embryo transfer cycle cancellation were similar in both groups.
DISCUSSION
Different methods of assisted reproduction such as superovulation with IUI (9), fallopian tube sperm perfusion (FSP) (10), DIPI (2-4), gamete intrafallopian tube (GIFT) transfer (11) , and IVF (12) have been used for the treatment of unexplained infertility. We (4) reported women with unexplained infertility who failed to conceive after repeated superovulation and IUI had a favorable outcome when treated with a combination of DIPI and GnRHa/hMG/hCG without complications. DIPI is less expensive and invasive than either IVF-ET or GIFT. Therefore, we performed DIPI on women with unexplained infertility who failed to conceive after repeated superovulation and IUI prior to more invasive assisted reproductive techniques, such as IVF-ET or GIFT. It is unknown, however, whether lack of conception with such treatment options dictates a less favorable prognosis for future attempts at a more complex form of assisted conception methods such as IVF. Our results indicate that couples with unexplained infertility who fail to conceive after four to six cycles of superovulation and DIPI have relatively good conception rates in subsequent IVF-ET. When compared with endometriosis or tubal factor patients undergo-ing similar treatment, however, they showed a higher incidence of total fertilization failure. Fertilization rates were not similar in two groups when events of total fertilization failure were excluded from analysis of data. Kahn et al. (10) , Gurgan et al. (5) , and Ruiz et al. (6) reported total failure of fertilization in 30.0%, 20.4%, 11.4%, respectively, of cases of unexplained infertility undergoing IVF after failure of superovulation and IUI. Audibert et al. (12) reported total failure of fertilization in 22.7% of cases of unexplained infertility. The rate of total fertilization failure in our study (30.2%) was slightly higher than theirs. The reason for the discrepancy may be explained by the fact that pregnancy rate per cycle with superovulation and DIPI even in patients with unexplained infertility failing to conceive after four to six cycles of superovulation and IUI is 35.6% in our data (4) . Because the rate of the low or total fertilization failure with unexplained infertility was higher than tubal and endometriosis infertility, the cancellation of embryo transfer with unexplained infertility was higher than tubal and endometriosis infertility (Table I) .
In the present study, although the fertilization rate obtained with ICSI was lower in patients with previous failed fertilization or a low fertilization rate than in patients with male factor, it was still 85.8%, which is higher than in other reports (13, 14) . The reason for the difference might be due to absent or abnormal oocyte activation (15) . Similar findings also were reported by Gabrielsen et al. (16) . In contrast to our and previous studies, Tomas et al. (13) and Miller et al. (14) reported fertilization rates obtained with ICSI to be similar in patients with previous failed fertilization or a low fertilization rate and in patients with male factor. The reason for failed fertilization after conventional IVF programs may reside in abnormal spermatozoa and/or oocytes, with lack of penetration of the zona pellucida and the ooplasmic membrane. This problem can be resolved partly by ICSI so that acceptable rates of fertilization can be achieved, as shown here.
In the present study, the implanation and pregnancy rates obtained with ICSI were similar in patients with previous failed fertilization or a low fertilization rate to those in the male factor group, in line with the findings of Ruiz et al. (6) and Svalander et al. (17) . In contrast, Tomas et al. (13) and Miller et al. (14) reported implanation and pregnancy rates obtained with ICSI to be lower in patients with previous failed fertilization or a low fertilization rate than in patients with male factor. Maternal age was older in patients with previous failed fertilization or a low fertilization rate than in patients with male factor, in the reports of Tomas et al. (13) and Miller et al. (14) , but in our study was similar in both groups. Implanation failure in older women could be due to aneuploidy as noted by Munne et al. (18) . Therefore, it is possible that embryos with ICSI from older women with previous failed fertilization or a low fertilization rate may have genetic defects that prevent normal embryonic development.
In summary, the present study demonstrated that once a failed cycle has occurred in patients with unexplained infertility failing to conceive after four to six cycles of superovulation and DIPI, ICSI should be the method of choice in a second attempt to avoid failed fertilization or a low fertilization rate, because fertilization failure in couples with unexplained infertility appears to be more likely to recur than in tubal factor patients (5) .
